tiprankstipranks
Trending News
More News >
ImageneBio (IMA)
NASDAQ:IMA
US Market
Advertisement

ImageneBio (IMA) Drug Pipeline

Compare
106 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Ik-595
Colorectal Cancer, Pancreatic Cancer, Non-small Cell Lung Carcinoma, Malignant Melanoma, Solid Tumor, Adult, Thyroid Carcinoma, Ras (Kras Or Nras) Gene Mutation, Braf Gene Mutation, Craf Gene Mutation, Gliomas, Malignant
Phase I
Terminated
Study of IK-595 in RAS- or RAF-altered Advanced Tumors
Jan 31, 2024
Osimertinib, Ik-930
Solid Tumor, Solid Tumors, Adult, Malignant Pleural Mesothelioma (Mpm), Epithelioid Hemangioendothelioma (Ehe), Nf2 Deficient Mesothelioma, Other Nf2 Deficient Solid Tumors And Solid Tumors With Yap1/Taz Fusion Genes, Nf2 Deficiency, Yap1 Or Taz Gene Fusions
Phase I
Terminated
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors
Jan 07, 2022

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does ImageneBio (IMA) have in its pipeline
      IMA is currently developing the following drugs: Ik-595, Osimertinib, Ik-930. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis